Market Place
Sourcing Support
All News #Library
Rare Diseases
Recordati Rare Diseases To Present New Data at ASH Meeting
04 Nov 2025 //
PR NEWSWIRE
Recordati Q1 2025 Revenue Up 11.9%, Profits Rise
08 May 2025 //
GLOBENEWSWIRE
Recordati: FDA Expands Isturisa Indication for Cushing`s Syndrome
16 Apr 2025 //
GLOBENEWSWIRE
Recordati buys rights to rare immune drug from Sanofi for $825 mln
05 Oct 2024 //
REUTERS
Recordati Rare Diseases Inc. Announces Availability of ISTURISA®
26 May 2020 //
BUSINESSWIRE
Recordati & Helsinn Agreement For Commercialization Rights To Ledaga®
18 Dec 2018 //
GLOBENEWSWIRE
CVC revs up rare disease ambitions with $3.5B Recordati buy
05 Jul 2018 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.